| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-02 16:51:00 UTC |
|---|
| Updated at | 2022-09-02 16:51:01 UTC |
|---|
| NP-MRD ID | NP0159141 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1s,2r,3s,4r,5s)-8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol |
|---|
| Description | Calystegine B2, also known as calystegine b(3), belongs to the class of organic compounds known as tropane alkaloids. These are organic compounds containing the nitrogenous bicyclic alkaloid parent N-Methyl-8-azabicyclo[3.2.1]Octane. (1s,2r,3s,4r,5s)-8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol is found in Acherontia atropos. (1s,2r,3s,4r,5s)-8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol was first documented in 2012 (PMID: 22148579). Based on a literature review a significant number of articles have been published on Calystegine B2 (PMID: 35845638) (PMID: 30579118) (PMID: 30245074) (PMID: 27161660) (PMID: 24657053) (PMID: 23697377). |
|---|
| Structure | O[C@@H]1[C@@H]2CC[C@@](O)(N2)[C@H](O)[C@H]1O InChI=1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6+,7-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1,2,3,4-Tetrahydroxy-nor-tropane | MeSH | | Calystegine b(2) | MeSH | | Calystegine b(3) | MeSH | | Calystegine b(4) | MeSH | | Calystegine b3 | MeSH | | Calystegine b4 | MeSH |
|
|---|
| Chemical Formula | C7H13NO4 |
|---|
| Average Mass | 175.1840 Da |
|---|
| Monoisotopic Mass | 175.08446 Da |
|---|
| IUPAC Name | (1S,2R,3S,4R,5S)-8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol |
|---|
| Traditional Name | (1S,2R,3S,4R,5S)-8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | O[C@@H]1[C@@H]2CC[C@@](O)(N2)[C@H](O)[C@H]1O |
|---|
| InChI Identifier | InChI=1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6+,7-/m0/s1 |
|---|
| InChI Key | FXFBVZOJVHCEDO-FHKSGDNWSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tropane alkaloids. These are organic compounds containing the nitrogenous bicyclic alkaloid parent N-Methyl-8-azabicyclo[3.2.1]Octane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Tropane alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Tropane alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tropane alkaloid
- Piperidine
- Cyclic alcohol
- Pyrrolidine
- Hemiaminal
- Secondary alcohol
- Alkanolamine
- Secondary aliphatic amine
- Polyol
- Azacycle
- Secondary amine
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Alcohol
- Hydrocarbon derivative
- Amine
- Organic nitrogen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Hampejsova R, Berka M, Berkova V, Jersakova J, Domkarova J, von Rundstedt F, Frary A, Saiz-Fernandez I, Brzobohaty B, Cerny M: Interaction With Fungi Promotes the Accumulation of Specific Defense Molecules in Orchid Tubers and May Increase the Value of Tubers for Biotechnological and Medicinal Applications: The Case Study of Interaction Between Dactylorhiza sp. and Tulasnella calospora. Front Plant Sci. 2022 Jun 30;13:757852. doi: 10.3389/fpls.2022.757852. eCollection 2022. [PubMed:35845638 ]
- Underlin EN, Jensen HH: Synthesis of nortropane alkaloid calystegine B(2) from methyl alpha-d-xylopyranoside. Carbohydr Res. 2019 Jan 15;472:122-126. doi: 10.1016/j.carres.2018.12.002. Epub 2018 Dec 7. [PubMed:30579118 ]
- Romera-Torres A, Romero-Gonzalez R, Martinez Vidal JL, Garrido Frenich A: Analysis of calystegines in tomato-based products by liquid chromatography-Orbitrap mass spectrometry. J Chromatogr A. 2018 Nov 16;1576:51-57. doi: 10.1016/j.chroma.2018.09.030. Epub 2018 Sep 17. [PubMed:30245074 ]
- Wang HY, Kato A, Kinami K, Li YX, Fleet GW, Yu CY: Concise synthesis of calystegines B2 and B3via intramolecular Nozaki-Hiyama-Kishi reaction. Org Biomol Chem. 2016 Jun 7;14(21):4885-96. doi: 10.1039/c6ob00697c. Epub 2016 May 10. [PubMed:27161660 ]
- Kato A, Nakagome I, Nakagawa S, Koike Y, Nash RJ, Adachi I, Hirono S: Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease. Bioorg Med Chem. 2014 Apr 15;22(8):2435-41. doi: 10.1016/j.bmc.2014.02.057. Epub 2014 Mar 12. [PubMed:24657053 ]
- Jockovic N, Fischer W, Brandsch M, Brandt W, Drager B: Inhibition of human intestinal alpha-glucosidases by calystegines. J Agric Food Chem. 2013 Jun 12;61(23):5550-7. doi: 10.1021/jf4010737. Epub 2013 Jun 3. [PubMed:23697377 ]
- Kyne SH, Miles JA, Percy JM, Singh K: Executing and rationalizing the synthesis of a difluorinated analogue of a ring-expanded calystegine B2. J Org Chem. 2012 Jan 20;77(2):991-8. doi: 10.1021/jo2022845. Epub 2011 Dec 30. [PubMed:22148579 ]
- LOTUS database [Link]
|
|---|